FDA urged to block generic non-tamper-proof pills

Painkillers without added safety features are expected to flood back into communities in the coming weeks unless the U.S. Food and Drug Administration takes preventive action, according to a national organization dedicated to reducing prescription drug abuse. Many popularly abused prescription painkillers, including OxyContin, have been reformulated in recent years to allegedly make them abuse-resistant. But many generic manufacturers are vying to bring their own versions of such drugs to market that don’t include tamper-proof properties. The FDA could allow these generic versions of the old formulations of the drugs to return to the market as early as January 2013, CLAAD says.

Earlier this month, CLAAD and nine other public health and safety organizations sent a letter to the FDA urging the agency to prevent the marketing of generic versions of the drugs that lack abuse-deterrent features.

The reformulation of OxyContin has prompted painkiller addicts across the country to switch to other opiates as well as heroin, recent research has shown.

About Erin Marie Daly

I’m a freelance journalist based in San Francisco. My book on prescription drug and heroin addiction was published in August 2014 by Counterpoint Press.
This entry was posted in Informational, Pharmaceutical Industry, Policy & Regulation and tagged , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *